NCT02524223View on ClinicalTrials.gov

Prevalence of HPV Transmission During Medically Assisted Procreation Procedures

NACompletedINTERVENTIONAL
Enrollment

915

Participants

Timeline

Start Date

July 12, 2012

Primary Completion Date

February 22, 2016

Study Completion Date

February 22, 2016

Conditions
Human Papillomavirus (HPV)Medically Assisted Procreation (MAP)Infertility
Interventions
OTHER

Systematic HPV DNA assay in semen and cervicovaginal scrape

Screening of HPV status at the genital level of males enrolled in MAP program.

OTHER

Systematic HPV DNA cervicovaginal scrape

Screening of HPV status at the genital level of females enrolled in MAP program.

OTHER

systematic HPV Status in newborns in case of pregnancy

Trial Locations (5)

33000

CHU de BORDEAUX, Bordeaux

42055

CHU de SAINT-ETIENNE, Saint-Etienne

63000

CHU de CLERMONT-FERRAND, Clermont-Ferrand

75018

Hôpital BICHAT, Paris

93140

Hôpital Jean VERDIER, Bondy

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT02524223 - Prevalence of HPV Transmission During Medically Assisted Procreation Procedures | Biotech Hunter | Biotech Hunter